Valuation: DiaSorin S.p.A.

Market Cap 3.72B 4.34B 3.48B 3.19B 5.98B 415B 6.06B 41.12B 16.03B 209B 16.3B 15.95B 690B P/E 2026 *
21.8x
P/E 2027 * 19.2x
Enterprise Value 4.43B 5.17B 4.14B 3.79B 7.11B 494B 7.21B 48.93B 19.08B 248B 19.4B 18.98B 821B EV / Sales 2026 *
3.59x
EV / Sales 2027 * 3.25x
Free-Float
37.17%
Yield 2026 *
1.73%
Yield 2027 * 1.81%
1 day+0.56%
1 week+0.97%
Current month+4.56%
1 month+11.45%
3 months+15.25%
6 months+7.01%
Current year+9.50%
1 week 72.84
Extreme 72.84
75.24
1 month 63
Extreme 63
76.58
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
1/28/26 A Buy

Chief Executive Officer

7,500 0.0134%
1/8/26 A Buy

Director

700 0.0013%
1/8/26 A Buy

Director

1,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
+0.56%+0.97%-12.93%-15.99% 4.34B
+1.67%+8.57%+178.54%+352.16% 22.91B
-0.13%+1.92%-41.52%-19.91% 10.24B
+1.96%+16.10%+397.10%+40.59% 8.48B
+6.88%+20.50%-31.09% - 7.42B
-0.27%-0.97%+68.98%+48.50% 6.53B
-4.95%+1.23%-12.97%-3.17% 6.06B
+1.49%-3.43%+69.95%+106.00% 4.41B
-0.86%+2.76%-17.52%-26.19% 2.94B
-4.22%-8.21%-55.18%+172.35% 1.39B
Average +0.21%+3.87%+54.34%+72.70% 7.47B
Weighted average by Cap. +0.98%+6.47%+97.67%+134.70%

Financials

2026 *2027 *
Net sales 1.23B 1.44B 1.16B 1.06B 1.98B 138B 2.01B 13.65B 5.32B 69.26B 5.41B 5.29B 229B 1.31B 1.53B 1.23B 1.12B 2.11B 146B 2.13B 14.48B 5.65B 73.49B 5.74B 5.62B 243B
Net income 181M 211M 169M 155M 290M 20.17B 294M 2B 778M 10.13B 791M 774M 33.51B 205M 240M 192M 176M 330M 22.95B 335M 2.27B 886M 11.53B 901M 881M 38.14B
Net Debt 707M 825M 661M 605M 1.14B 78.92B 1.15B 7.81B 3.05B 39.65B 3.1B 3.03B 131B 541M 632M 507M 464M 870M 60.48B 882M 5.99B 2.33B 30.38B 2.37B 2.32B 100B
Logo DiaSorin S.p.A.
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.
Employees
3,260
Date Price Change Volume
21/08/26 €75.14 +0.56% 93,397
20/08/26 €74.72 +1.60% 141,199
19/08/26 €73.54 -0.24% 110,835
18/08/26 €73.72 -1.05% 92,859
17/08/26 €74.50 +0.11% 97,961
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
75.14EUR
Average target price
71.66EUR
Spread / Average Target
-4.63%

Quarterly revenue - Rate of surprise